Skip to Content
scroll

Mesoblast (MSB)

ASX.MSB $0.83

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

LEARN MORE

MSB $0.83

20 MINUTE DELAYED

TODAY

0.00 %

1 YEAR RETURN

0.00%

VOLUME

0

DIV YIELD

0%

PE RATIO

0.00

52 WEEK RANGE

0.26

1.35

ANALYSIS

i

SHARE PRICE ACTIVITY
Last (Price)

0.83

Change

0.00 (0.00)

Bid / Ask

0.85 - 0.80

Volume

0

Turnover

0

Open

0.00

Day Range

0.81 - 0.84

VWAP

0.00

Prev Close

0.83

Last Trade

16/04 8:19am (AEST)

i

KEY INFORMATION
Sector

Healthcare

Shares Issued

890,565,210

NTA/Share

0.00

Last Dividend

0.00

Dividend Ex Date

0

Dividend Pay Date

22 MAR 2006

i

BROKER CALLS

current

Mean

2.00

Target Price

0.00

BUY

i

CURRENT ()
Revenue

7.50

EBITDA

-57.87

Profit

-81.89

Earnings Per Share (EPS)

0

Dividend Per Share (DPS)

0

Yield %

0.00

Market Cap

0

Price to Earnings Ratio (P/E)

0

i

TARGET PRICE FORECAST

i

ESTIMATES ()
Revenue

6.40

EBITDA

-48.12

Profit

-67.41

Earnings Per Share (EPS)

-0.39

Dividend Per Share (DPS)

0.00

i

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation (BUY)

2.00
OPINION
ACTION
image description

Business Summary

Mesoblast (MSB) provides biomedical services. The Company develops drugs for cardiovascular  diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its  business worldwide.

image description

Relevant suggested news and content from the site

image description

Only available to Members

Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing. Click here
Back to top